Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,280,329
-$173,578 QoQ
Shares Held
10,134
-2.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
#973
of 2,266 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Verity Asset Management, Inc. holds $13,024,966 across 11 Drug Manufacturers - General names. GILD ranks #5 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
8,729 | $3,160,945 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
31,404 | $1,809,498 | |
| 3 | JNJ |
Johnson & Johnson
|
5,968 | $1,515,692 | |
| 4 | GSK |
GSK plc
|
25,025 | $1,311,810 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
10,134 | $1,280,329 | |
| 6 | MRK |
Merck & Co., Inc.
|
8,942 | $1,149,047 | |
| 7 | LLY |
ELI LILLY & Co
|
569 | $682,475 | |
| 8 | ABBV |
AbbVie Inc.
|
2,707 | $681,189 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,280,329 | 10,134 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,453,907 | 10,432 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,271,218 | 10,357 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $2,285,934 | 20,594 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,307,600 | 11,794 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $2,716,092 | 24,240 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $1,095,231 | 11,857 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $910,502 | 10,860 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $603,356 | 8,794 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $635,150 | 8,671 | Shares | Sole | 2024-05-28 | |
| 2023-12-31 | $707,298 | 8,731 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $641,711 | 8,563 | Shares | Sole | 2023-11-22 | |
| 2023-06-30 | $586,888 | 7,615 | Shares | Sole | 2023-08-16 | |
| 2023-03-31 | $640,860 | 7,724 | Shares | Sole | 2023-05-24 | |
| 2022-12-31 | $687,744 | 8,011 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $764,647 | 12,395 | Shares | Sole | 2022-11-16 | |
| 2022-03-31 | $672,736 | 11,316 | Shares | Sole | 2022-05-23 | |
| 2021-12-31 | $538,185 | 7,412 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,058,576 | 15,155 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,026,564 | 14,908 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $688,568 | 10,654 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $492,063 | 8,446 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $599,673 | 9,490 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $533,732 | 6,937 | Shares | Sole | 2020-11-13 | |
| 2020-03-31 | $279,751 | 3,742 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||